SCHEMBL2227987

SCHEMBL2227987

CC(C)c1ccc(Nc2cc(NCc3cc(S(N)(=O)=O)ccc3OCC(F)(F)F)ncn2)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 5/20 0.49
TNNI3K Q59H18 6/20 0.41
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
EGFR P00533 2/20 0.36
ERBB3 P21860 2/20 0.36
ABL1 P00519 2/20 0.35
BCR P11274 2/20 0.35
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
CHRNA7 P36544 1/20 0.34
PTGS2 P35354 1/20 0.34
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225786 0.88 BRAF (0.50) BRAFTNNI3KKDM4EGAAEGFR
SCHEMBL2225876 0.87 BRAF (0.63) BRAFTNNI3KKDM4EGAAEGFR
SCHEMBL2226948 0.85 BRAF (0.48) BRAFTNNI3KKDM4EGAAEGFR
SCHEMBL2228424 0.80 TNNI3K (0.61) BRAFTNNI3KEGFRERBB3ABL1
SCHEMBL2226257 0.79 TNNI3K (0.49) BRAFTNNI3KKDM4EGAAEGFR
SCHEMBL14323163 0.79 BRAF (0.77) BRAFTNNI3KEGFR
SCHEMBL2226387 0.79 BRAF (0.51) BRAFTNNI3KEGFRERBB3LMNA
SCHEMBL2225198 0.78 TNNI3K (0.48) BRAFTNNI3KEGFRERBB3ABL1
SCHEMBL2227178 0.77 TNNI3K (0.61) BRAFTNNI3KEGFRABL1BCR
SCHEMBL2225756 0.76 BRAF (0.62) BRAFTNNI3KEGFRERBB3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed